ArticleBMC medical genomics2026
Shared molecular signatures between atrial fibrillation and chronic obstructive pulmonary disease: an integrated bioinformatic analysis with experimental validation.
Article in BMC medical genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundAtrial fibrillation (AF) and chronic obstructive pulmonary disease (COPD) are highly prevalent conditions that significantly impact patient outcomes. While mounting evidence suggests a strong epidemiological and clinical association between AF and COPD, the molecular basis underlying their frequent co-occurrence remains incompletely characterized. Rather than inferring direct disease-specific mechanistic links, this study aimed to identify shared systemic inflammatory and immune-related transcriptional signatures that are detectable across different tissues in AF and COPD.
resultsA total of 208 DEGs were found to be shared between AF and COPD. Functional enrichment analyses indicated that these genes were predominantly associated with inflammatory, immune, and extracellular matrix–related biological processes, including the NOD-like receptor, Influenza A, Phospholipase D, and ECM-receptor interaction pathways. PPI network analysis and external dataset verification highlighted CASP1, CXCR2, and IFIT5 as reproducibly upregulated genes across independent AF and COPD transcriptomic datasets. Their elevated expression was further observed in AF, COPD, and comorbid samples in exploratory validation experiments. No single TF or miRNA was found to simultaneously regulate all three genes, suggesting heterogeneous and context-dependent regulatory patterns rather than a unified regulatory axis. Drug–gene association analysis identified estradiol and methyl methanesulfonate as compounds computationally linked to the shared gene set, without implying biological efficacy or therapeutic applicability.
conclusionThis study delineates shared inflammatory and immune-related transcriptional signatures observed across AF and COPD datasets, highlighting common pathways and candidate genes that may reflect systemic inflammatory states. These findings are hypothesis-generating and primarily reflect shared systemic inflammatory and immune responses rather than disease-specific causal mechanisms, providing a bioinformatic framework for future mechanistic and clinical investigations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.